scispace - formally typeset
S

Shijun Sun

Researcher at Peking University

Publications -  12
Citations -  312

Shijun Sun is an academic researcher from Peking University. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 4, co-authored 9 publications receiving 93 citations.

Papers
More filters
Journal ArticleDOI

The Changing Pattern of Population Structure of Staphylococcus aureus from Bacteremia in China from 2013 to 2016: ST239-030-MRSA Replaced by ST59-t437.

TL;DR: It is revealed that fitness advantage of ST59-t437- MRSA over ST239-t030-MRSA may lead to changes in genetic structure and increased susceptibility of MRSA to rifampicin and fluoroquinolones in Chinese patients with S. aureus bacteremia.
Journal ArticleDOI

Co-existence of a novel plasmid-mediated efflux pump with colistin resistance gene mcr in one plasmid confers transferable multidrug resistance in Klebsiella pneumoniae

TL;DR: A plasmid-mediated tigecycline resistance mechanism, a 6,489 bp Resistance-nodulation-division family (RND) efflux pump (tmexCD1-toprJ1 pump), that confers transferable tigECyclines resistance in K pneumoniae isolated from patients and chickens is reported.
Journal ArticleDOI

Role of mobile genetic elements in the global dissemination of the carbapenem resistance gene blaNDM

TL;DR: The authors in this article developed a computational approach to track structural variants surrounding blaNDM, which allows them to identify prevalent genomic contexts, mobile genetic elements, and likely events in the gene's global spread.
Journal ArticleDOI

Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections

TL;DR: In this paper, the authors used three control groups (external negative controls under long-term surveillance, blood samples with a negative result in conventional tests, and a group of healthy people) to distinguish contaminants arising from specimen collection, sample processing, and human normal flora.
Journal ArticleDOI

Retrospective Observational Study from a Chinese Network of the Impact of Combination Therapy versus Monotherapy on Mortality from Carbapenem-Resistant Enterobacteriaceae Bacteremia.

TL;DR: The severity of illness, meropenem MICs of >8 mg/liter, and carbapenemase-producing types were associated with the clinical outcome and survival analysis revealed appropriate therapy was associated with a lower 14-day mortality rate than inappropriate therapy, and combination therapy was superior to monotherapy.